OncoSurge: a strategy for improving resectability with curative intent in metastatic colorectal cancer. - Wikidata - awgldk - TriplyDB

OncoSurge: a strategy for improving resectability with curative intent in metastatic colorectal cancer.

OncoSurge: a strategy for improving resectability with curative intent in metastatic colorectal cancer.

http://www.wikidata.org/entity/Q34455189

about

LICC: L-BLP25 in patients with colorectal carcinoma after curative resection of hepatic metastases: a randomized, placebo-controlled, multicenter, multinational, double-blinded phase II trial Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies Resection of colorectal liver metastases and extra-hepatic disease: a systematic review and proportional meta-analysis of survival outcomes Colorectal cancer: Metastases to a single organ Role of surgery in colorectal cancer liver metastases Current approaches and challenges for monitoring treatment response in colon and rectal cancer Colorectal Liver Metastases: A Critical Review of State of the Art Is conversion therapy possible in stage IV gastric cancer: the proposal of new biological categories of classification Predictive and prognostic molecular markers for cancer medicine Neoadjuvant treatment for rectal cancer-A value-based proposition.Clinical significance of Neutrophil gelatinase-associated lipocalin(NGAL) expression in primary rectal cancer.Alternating systemic and hepatic artery infusion therapy for resected liver metastases from colorectal cancer: a North Central Cancer Treatment Group (NCCTG)/ National Surgical Adjuvant Breast and Bowel Project (NSABP) phase II intergroup trial, N99 Oxaliplatin, irinotecan and capecitabine as first-line therapy in metastatic colorectal cancer (mCRC): a dose-finding study and pharmacogenomic analysis.Resection of the primary tumour versus no resection prior to systemic therapy in patients with colon cancer and synchronous unresectable metastases (UICC stage IV): SYNCHRONOUS--a randomised controlled multicentre trial (ISRCTN30964555).Sequential surgical resection of hepatic and pulmonary metastases from colorectal cancer.Improvements in population-based survival of patients presenting with metastatic rectal cancer in the south of the Netherlands, 1992-2008.Breast Implant-associated Anaplastic Large Cell Lymphoma: Updated Results from a Structured Expert Consultation Process.Medical treatment of advanced colorectal cancer in 2009.Novel methods for clinical risk stratification in patients with colorectal liver metastases Cancerous inhibitor of protein phosphatase 2A (CIP2A) is an independent prognostic marker in wild-type KRAS metastatic colorectal cancer after colorectal liver metastasectomy Institutional guidelines and ongoing studies in management of liver tumours: the experience of the European Institute of Oncology.Adenosine triphosphate-based chemotherapy response assay-guided chemotherapy in unresectable colorectal liver metastasis.Curative strategies for liver metastases from colorectal cancer: a review Patterns of Care for Colorectal Liver Metastasis Within an Integrated Health System: Secular Trends and Outcomes.Bilobar spreading of colorectal liver metastases does not significantly affect survival after R0 resection in the era of interdisciplinary multimodal treatment Selective versus routine lymphadenectomy in the treatment of liver metastasis from colorectal cancer: a retrospective cohort study Anti-inflammatory liposomes have no impact on liver regeneration in rats Integrating Chemotherapy into the Management of Oligometastatic Colorectal Cancer: Evidence-Based Approach Using Clinical Trial Findings Resection of colorectal liver metastases: current perspectives.Postoperative mortality and need for transitional care following liver resection for metastatic disease in elderly patients: a population-level analysis of 4026 patients.The role of primary tumor resection in colorectal cancer patients with asymptomatic, synchronous unresectable metastasis: Study protocol for a randomized controlled trial Optimal treatment of metastatic colorectal cancer.Colorectal liver metastases: current and future perspectives.Neoadjuvant chemotherapy for patients with liver metastases from colorectal cancer.Metastatic colorectal cancer-past, progress and future Optimizing the approach to patients with potentially resectable liver metastases from colorectal cancer.Cetuximab in combination with irinotecan/5-fluorouracil/folinic acid (FOLFIRI) in the initial treatment of metastatic colorectal cancer: a multicentre two-part phase I/II study Liver angulometry: a simple method to estimate liver volume and ratios.Accomplishments in 2008 in the management of curable metastatic colorectal cancer.Palliative treatment of unresectable metastatic colorectal cancer.

P2860

Q21261279-BAA02439-9B6A-4368-9F39-C7FE6ACA7263 Q24651894-6A99AB3C-5F60-451D-8B0F-EF78150687E8 Q26750691-C59BC71C-76D5-46B3-ADDB-A24098C717A2 Q26778009-20FFD15C-4BCB-4444-A636-36F226BD4993 Q26830444-A8D67ECA-F5BA-4929-B2D7-137C4EBB386E Q27010257-FE423E77-4211-4FB6-94A0-331841D84B0C Q28070400-6B9D0570-7F79-41FE-B48F-D947238373B0 Q28084888-61196F42-0825-4C2A-A71E-EB15807DD51E Q28743108-A56A6FA9-2A34-474A-93AA-8B8DCD7489F1 Q30251516-698593C1-B4C6-4BD1-BA38-05AF8F43DA9E Q33440034-59AEA5F5-118C-4425-9483-523BCB7DA091 Q33710593-36D6BE3F-243B-42A4-B81F-9F9173B1469F Q33747440-052017D2-1398-4B74-83BA-456C9709A399 Q34222890-37504FC2-9A3D-4298-BB11-CD162CA89B24 Q34280511-EA5483F6-0059-485E-B288-C3CBF9C103A2 Q34579685-B2BAF0CF-BDC4-4B7E-9EBB-C917E496CFEF Q35069314-7F3B513D-517C-4F92-882D-EB1DCDC9939E Q35076194-9736BBCB-D97B-4F47-9FCE-E1991066CBBD Q35429661-5D7E3459-8900-42CB-A8C6-E6D3E266B013 Q35503680-83902165-8319-4714-962B-AADF0833D32C Q35602256-A003BA72-A3A2-4BC2-90D3-17A7FB13EEF2 Q35653726-C9400CB3-4553-431B-98CA-A081A8349A0E Q35776233-12A6729A-BC56-4EDF-8ABA-3E09A510F474 Q36061491-714FE4C9-0AFC-44CF-9B25-5C9AE0268BF6 Q36253364-7870ACEB-FC7D-41DA-98B8-0049085531A7 Q36334591-0374A818-2786-4BD9-9614-3DD231FE1498 Q36387936-DBFEB81C-DD02-4A64-BDA7-658072C9BD1F Q36396031-3746FED4-E9C6-47C0-8B34-A3069FFAB05C Q36409950-7DB22D1C-4BBB-46C7-9F6B-DD1D4761E686 Q36465704-025743CE-2AE5-43AE-BAE9-F0784ACDDA34 Q36476152-41C38783-66CB-43B6-93E4-0022C04CF1B9 Q36499255-3A963EF8-F7C4-4719-9F3F-C7FE14D73A83 Q36572540-5187C5AA-C001-463C-A409-DCBC32ABCD25 Q36842791-DA5D211A-2142-477C-9FDB-45C2C5DA6F11 Q36893806-E5455E3D-C61A-4A64-BE0B-AAD2DB1F943B Q36968386-2A73D50C-0F1C-4C05-BA43-C82CBA55E14E Q37182234-3BAE113F-7389-409A-8CBC-E03B35FE79C1 Q37350315-836097DD-82E8-4F35-8AE9-82C10CE04B26 Q37468824-5E2A8D1F-03DE-46FF-B215-73AE68D608CB Q37650308-F741766A-B9E9-4B02-841A-7611F82DF5C6

P2860

OncoSurge: a strategy for improving resectability with curative intent in metastatic colorectal cancer.

http://www.wikidata.org/entity/Q34455189

description

2005 nî lūn-bûn

@nan

2005 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

OncoSurge: a strategy for impr ...... metastatic colorectal cancer.

@ast

OncoSurge: a strategy for impr ...... metastatic colorectal cancer.

@en

OncoSurge: a strategy for impr ...... metastatic colorectal cancer.

@nl

type

label

OncoSurge: a strategy for impr ...... metastatic colorectal cancer.

@ast

OncoSurge: a strategy for impr ...... metastatic colorectal cancer.

@en

OncoSurge: a strategy for impr ...... metastatic colorectal cancer.

@nl

prefLabel

OncoSurge: a strategy for impr ...... metastatic colorectal cancer.

@ast

OncoSurge: a strategy for impr ...... metastatic colorectal cancer.

@en

OncoSurge: a strategy for impr ...... metastatic colorectal cancer.

@nl

P1433

Q34455189-43BB64D6-1729-4360-8056-040080405921

P1476

Q34455189-27C14B22-4456-41A5-8AB8-A053D573D69A

P2093

Q34455189-0CDFFE8F-8918-4042-AF6C-00154C70E2D8

Q34455189-11CB1A17-41DC-4E8E-BB58-67E78B7C38F3

Q34455189-121F8A63-419A-460B-B253-19DE96A7DA60

Q34455189-1CE4103A-75C2-4031-B888-7A7314E822FF

Q34455189-2950534D-E794-4718-A733-563F4FF02248

Q34455189-3CBA4A7B-E741-4B44-A3AA-DC4DE494E891

Q34455189-48885893-29F9-4CA6-B002-B87AEC782D4A

Q34455189-536DB890-913B-425D-A6D4-8B883BDB5B65

Q34455189-53B2E4DB-DD2E-4DD2-8DFD-A02D6A9854E2

Q34455189-57341619-5371-4A73-8293-20E3B8A3012C

P304

Q34455189-5BF75433-D665-42D7-B76F-0406B0A27DCB

P31

Q34455189-0F49088E-DB4F-46CA-B141-AEF651E2710D

P356

Q34455189-077DDE15-36D1-4E32-93BC-14F9436C85DC

P407

Q34455189-0BC10A35-8D78-4369-AE6B-B0C385088FC0

P433

Q34455189-FAD2F63E-F30C-4DBA-8E75-8B1044A6D334

P478

Q34455189-B7975053-47D7-47BD-8AAD-3398E1FC812B

P50

Q34455189-DC69F144-F27A-45E8-A5BD-4460353DACFD

P577

Q34455189-B2A33131-7038-4BA8-A118-AB523C4B8AB2

P698

Q34455189-E1FBA0F9-E862-45EA-A2B6-9D072F4431CB

P921

Q34455189-1E98274C-7D0E-4E64-830F-C82401C552B3

P356

JCO.2005.08.722

P1433

Journal of Clinical Oncology

P1476

OncoSurge: a strategy for impr ...... n metastatic colorectal cancer

@en

P2093

Bernard Nordlinger

http://www.w3.org/2001/XMLSchema#string

Carlos Valls

http://www.w3.org/2001/XMLSchema#string

Daniel Haller

http://www.w3.org/2001/XMLSchema#string

Francis Kunstlinger

http://www.w3.org/2001/XMLSchema#string

Gilles Mentha

http://www.w3.org/2001/XMLSchema#string

Graeme J Poston

http://www.w3.org/2001/XMLSchema#string

Hans Joachim Schmoll

http://www.w3.org/2001/XMLSchema#string

James P Kahan

http://www.w3.org/2001/XMLSchema#string

Juan Figueras

http://www.w3.org/2001/XMLSchema#string

Mark Roh

http://www.w3.org/2001/XMLSchema#string

P304

7125-7134

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2005.08.722

http://www.w3.org/2001/XMLSchema#string

P407

P433

28

http://www.w3.org/2001/XMLSchema#string

P478

23

http://www.w3.org/2001/XMLSchema#string

P50

P577

2005-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16192596

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer